Oncology (all articles)
Study Commentary | “Blood test finds 50 types of cancer” – we’ve been down this path before.
5 Jul, 2021 | 01:31h | UTC“Blood test finds 50 types of cancer” – we’ve been down this path before – HealthNewsReview
Original study: Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set – Annals of Oncology
RCT: Similar outcomes with 5 vs. 2 years of zoledronate treatment following adjuvant chemotherapy in early breast cancer.
1 Jul, 2021 | 09:50h | UTCOriginal Study: Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
1 Jul, 2021 | 09:44h | UTC
Commentary on Twitter
Now available in Annals of Oncology, the @myESMO clinical practice guidelines for the diagnosis, treatment and follow-up of anal cancer, a rare disease accounting for less than 1% of all cancers https://t.co/usnFsd00BJ pic.twitter.com/bI0v60j8Ft
— Annals of Oncology (@Annals_Oncology) June 30, 2021
Evidence-based clinical practice guidelines for management of colorectal polyps.
25 Jun, 2021 | 10:11h | UTC
RCT: Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer.
24 Jun, 2021 | 09:41h | UTCLutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Risk of atrial fibrillation according to cancer type: a nationwide population-based study – Multiple myeloma showed a higher association with incident AF (aHR: 3.34; 95% CI: 2.98 to 3.75). Esophageal cancer showed the highest risk among solid cancers (aHR: 2.69; 95% CI: 2.45 to 2.95).
21 Jun, 2021 | 08:37h | UTC
Commentary on Twitter
Patients with #cancer have a higher risk of atrial fibrillation, and its impact varies according to the type of cancer. https://t.co/j84td0oRck #epeeps #JACCCardioOnc #ACCCardioOnc #CardioOnc #AFib #CKD #CVD #MMsm #lymsm #leusm #melanoma #OpenAccess pic.twitter.com/ebXJJ3zYYY
— JACC Journals (@JACCJournals) June 19, 2021
AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.
21 Jun, 2021 | 08:38h | UTCTop Things to Know: Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology – American Heart Association
Review: venous and arterial thromboembolism in patients with cancer.
16 Jun, 2021 | 08:20h | UTCSummary: Venous and Arterial Thromboembolism in Patients With Cancer – American College of Cardiology
Viewpoint | Active surveillance as a management option for low-risk basal cell carcinoma.
15 Jun, 2021 | 08:49h | UTC
Radiology malpractice cases most often involve cancer-related diagnostic errors.
10 Jun, 2021 | 09:27h | UTCRadiology malpractice cases most often involve cancer-related diagnostic errors – Health Imaging
Original study: Oncologic Errors in Diagnostic Radiology: A 10-Year Analysis Based on Medical Malpractice Claims – Journal of the American College of Radiology (link to abstract – $ for full-text)
RCT: Heart-protecting drugs likely unnecessary for most breast cancer patients undergoing adjuvant treatment.
8 Jun, 2021 | 09:15h | UTCCommentaries: Heart-protecting drugs likely unnecessary for many breast cancer patients – American College of Cardiology
RCT: Adjuvant Nivolumab vs. Placebo in Muscle-Invasive Urothelial Carcinoma.
3 Jun, 2021 | 10:36h | UTC
After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.
2 Jun, 2021 | 08:34h | UTC
AUA Guideline | Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow Up.
2 Jun, 2021 | 08:27h | UTCCommentary: AUA updates guideline on renal masses and localized renal cancer – Urology Times
Guideline | Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors.
31 May, 2021 | 08:09h | UTC
Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work.
26 May, 2021 | 08:18h | UTC
State-of-the-Art Review: Clinical approach to cardiovascular toxicity of oral antineoplastic agents
26 May, 2021 | 08:20h | UTCSummary: Cardiovascular Toxicity of Oral Antineoplastic Agents – American College of Cardiology
M-A: A biofeedback‐guided program or pelvic floor muscle electric stimulation can improve early recovery of urinary continence after radical prostatectomy.
26 May, 2021 | 08:13h | UTC
A deep learning algorithm can estimate malignancy risk of pulmonary nodules detected at low-dose screening CT.
24 May, 2021 | 08:21h | UTCCommentaries: AI predicts lung cancer risk – Radiological Society of North America AND AI Takes LDCT Further for Lung Cancer Prediction – Diagnostic Imaging
Commentary on Twitter
A deep learning algorithm can have a discriminative performance comparable to that of clinical experts on low-dose screening chest CTs. https://t.co/60U518u6eA pic.twitter.com/phZPFDpUpx
— Radiology (@radiology_rsna) May 20, 2021
RCT: Reduced-intensity chemotherapy among older and frail patients with advanced gastroesophageal cancer provides an improved patient experience with no significant detriment in cancer control.
20 May, 2021 | 08:18h | UTC
Commentary on Twitter
The GO2 trial tested reduced intensity of chemo for pts w adv gastroesophageal cancer & found reducing intensity led to comparable survival but w improved patient experience, & decision-making can be enhanced using geriatric assessment https://t.co/DtZOXcozo7 #GeriOnc
— JAMA Oncology (@JAMAOnc) May 13, 2021
Randomized trial long-term results confirm the benefits of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer
20 May, 2021 | 08:16h | UTC
Commentaries on Twitter
Out at @ASCO_pubs
🔟yr Outcome of Neoadj #Chemoradiotherapy➕Surgery for #EsophagealCancer☑️Show OS benefit in locally advanced resectable esophageal or junctional #Cancer who receive preop chemorad🧪☢️ According to CROSS, persists at least🔟years‼️https://t.co/yJSibSveAh pic.twitter.com/UssnzuFiEe
— Gil Morgan, MD (@weoncologists) May 14, 2021
Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists – 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck pic.twitter.com/2JwV0iOvoB
— Journal of Clinical Oncology (@JCO_ASCO) May 5, 2021
Systematic review: Autoimmune encephalitis related to cancer treatment with immune checkpoint inhibitors – nivolumab was responsible for 61% of cases; onset occurred after a median of 3.5 treatment cycles, but very early and late presentations were common
20 May, 2021 | 08:13h | UTCAutoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review – Neurology (link to abstract – $ for full-text)
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
19 May, 2021 | 08:40h | UTCScreening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Evidence Report: Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Editorials: US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty – JAMA AND Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better – JAMA Surgery AND Colorectal Cancer Screening Starting at Age 45 Years—Ensuring Benefits Are Realized by All – JAMA Network Open AND
Modeling study: Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force – JAMA
Author interview: USPSTF Recommendation: Screening for Colorectal Cancer
JAMA Patient Page: Screening for Colorectal Cancer
Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.
19 May, 2021 | 08:23h | UTCRelated Guidelines:
See also: Enhanced Recovery After Surgery (ERAS) Society Guidelines
AI-based pathology predicts origins for cancers of unknown primary.
18 May, 2021 | 07:11h | UTCAI-based pathology predicts origins for cancers of unknown primary – Nature
Commentary on Twitter
A paper published in Nature presents a deep-learning algorithm for classification of cancers of unknown primary origin. https://t.co/IZQ13XWzJn pic.twitter.com/WjKW3kQz3N
— Nature Portfolio (@NaturePortfolio) May 15, 2021